NASDAQ: ETRA
Electra Therapeutics Inc Stock Ownership - Who owns Electra Therapeutics?

Insider buying vs selling

Have Electra Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Carl L. GordonDirector2026-09-21333,333$15.00
$5.00MBuy
Carl L. GordonDirector2026-09-211,000,000$15.00
$15.00MBuy
Orbimed Advisors LLCDirector2026-09-21333,333$15.00
$5.00MBuy
Orbimed Advisors LLCDirector2026-09-211,000,000$15.00
$15.00MBuy

1 of 1

ETRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ETRA insiders and whales buy or sell their stock.

ETRA Shareholders

What type of owners hold Electra Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Westlake Biopartners Fund I LP4.62%2,820,403$22.85MInsider
Carl L. Gordon2.88%1,758,279$14.24MInsider
Orbimed Advisors LLC2.88%1,758,279$14.24MInsider
Quehuong Kathy Dong0.75%455,484$3.69MInsider
Nancy Stagliano0.42%255,635$2.07MInsider
Graham Parry0.14%85,504$692.58kInsider
Gary S. Koe0.10%63,656$515.61kInsider

1 of 1

ETRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AARD0.04%46.39%Net SellingNet Selling
ABVC0.00%78.89%
ABVX0.07%0.00%
ACET0.04%99.96%Net Buying
TRXB0.00%37.74%Net BuyingNet Buying

Electra Therapeutics Stock Ownership FAQ

Who owns Electra Therapeutics?

Electra Therapeutics (NASDAQ: ETRA) is owned by 0.00% institutional shareholders, 11.78% Electra Therapeutics insiders, and 88.22% retail investors. Westlake Biopartners Fund I LP is the largest individual Electra Therapeutics shareholder, owning 2.82M shares representing 4.62% of the company. Westlake Biopartners Fund I LP's Electra Therapeutics shares are currently valued at $20.62M.

If you're new to stock investing, here's how to buy Electra Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.